Thorne Healthtech, Inc.

THRN | $10.19 0.1% 85K

(0.0% 1d) (-0.1% 1m) (121.5% 1y) (-0.1% 2d) (0.1% 3d) (0.0% 7d) (Infinity% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 549,445,004
https://www.thorne.com
Sec Filling | Patents | 2021 employees

Thorne is a health and technology company, and one of two vertically integrated brands under Thorne HealthTech, a leader in developing innovative solutions for a personalized approach to health and wellbeing. By combining testing with nutritional supplement interventions and diet, exercise and lifestyle recommendations, Thorne is at the forefront of personalized health, with a mission to help consumers take control of their health and live a healthy life. By leveraging its sophisticated analytical software, Thorne helps consumers uncover health insights and confidently take action to optimize health outcomes. Based on individual test results, Thorne's technology and team can deliver a personalized plan on what to eat, how to exercise and which Thorne supplements to take. Thorne is also a proud partner of several U.S. Olympic Teams.

optical brands ycombinator

add to watch list Paper trade email alert is off

Press-releases

L Catterton Makes Strategic Investment in Sploot Veterinary Care
Published: 2024-01-16 (Crawled : 15:30) - prnewswire.com
THRN | $10.19 0.1% 85K

| Email alert Add to watchlist
veterinary care

THORNE HEALTHTECH ANNOUNCES INNOVATION ARM UNDER THORNE VENTURES
Published: 2023-12-20 (Crawled : 14:30) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -6.66% | O: 0.73% H: 0.0% C: 0.0%
arm innovation

Hi!Papa Completes Series A+ Fundraise Led by L Catterton
Published: 2023-12-20 (Crawled : 02:00) - prnewswire.com
THRN | $10.19 0.1% 85K

| Email alert Add to watchlist
series

L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer
Published: 2023-10-13 (Crawled : 12:00) - prnewswire.com
THRN | $10.19 0.1% 85K

| -0.1% | O: -0.1% H: 0.1% C: 0.0%

Thorne HealthTech Reports Second Quarter 2023 Results
Published: 2023-08-08 (Crawled : 20:00) - prnewswire.com
THRN | $10.19 0.1% 85K

| 78.77% | O: 8.77% H: 0.0% C: -3.55%
results

Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8
Published: 2023-08-01 (Crawled : 22:00) - prnewswire.com
THRN | $10.19 0.1% 85K

| 79.72% | O: -2.12% H: 8.29% C: 6.85%
conference

Thorne HealthTech to Participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10
Published: 2023-07-28 (Crawled : 15:00) - biospace.com/
THRN | $10.19 0.1% 85K

| 75.39% | O: 3.27% H: 1.83% C: -1.17%
conference growth

Thorne HealthTech to Participate in TD Cowen's 7th Annual Future of the Consumer Conference on June 7
Published: 2023-05-30 (Crawled : 20:00) - prnewswire.com
THRN | $10.19 0.1% 85K

| 130.02% | O: 0.45% H: 7.42% C: -0.67%
conference

Thorne HealthTech Enters into Research and Development Partnership with Arome Science to Develop Next-Generation Metabolomics Test
Published: 2023-05-15 (Crawled : 16:00) - biospace.com/
THRN | $10.19 0.1% 85K

| 108.81% | O: -1.64% H: 3.33% C: -2.92%
partnership test research

Thorne HealthTech Reports First Quarter 2023 Results
Published: 2023-05-11 (Crawled : 20:00) - prnewswire.com
THRN | $10.19 0.1% 85K

| 119.61% | O: -4.09% H: 12.36% C: 9.66%
results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001209191-23-053092	4	2023-10-18	2023-10-16	Sell	D	105874	0
0001209191-23-053091	4	2023-10-18	2023-10-16	Sell	D	2532050	0
0001209191-23-053091	4	2023-10-18	2023-10-16	Sell	D	208100	0
0001209191-23-053091	4	2023-10-18	2023-10-16	Sell	D	2105589	0
0001209191-23-053090	4	2023-10-18	2023-10-16	Sell	D	453455	0
0001209191-23-053090	4	2023-10-18	2023-10-16	Sell	D	5424550	0